USE OF AN IMINOSUGAR AS AN INHIBITOR OF EPITHELIAL CELL ADHESION

摘要

The invention relates to the human or animal use of an iminosugar in the prevention and/or coadjuvant treatment of bacterial infections, microbiota imbalances or diseases associated with microbiota imbalances. The invention also relates to the use of a combination of said sugar and bioactive agents for the aforementioned indications, and to a pharmaceutical composition containing said combination.